AstraZeneca · 10 hours ago
CPQP Summer Intern, PhD Students
AstraZeneca is seeking PhD level students for a 12-week internship role in Boston, MA. The internship will involve data handling, population PK/PD support, exposure–response analyses, clinical trial simulations, and contributions to QSP models.
BiopharmaBiotechnologyHealth CareMedicalPharmaceuticalPrecision Medicine
Responsibilities
Data handling and visualization: Clean, organize, and visualize clinical and preclinical datasets; generate plots to identify trends relevant to PK/PD and exposure–response
Population PK/PD support: Assist in model specification, parameter estimation, and diagnostics under mentorship; contribute to model summaries and interpretation
Exposure–response analyses: Support exploratory analyses that connect drug exposure to efficacy/safety endpoints; help prepare figures and concise findings
Clinical trial simulations: Run and document scenario analyses to explore dose/regimen implications, sample size, and study design options
QSP model contributions: Help curate literature, structure model components, and perform basic simulations in QSP platforms under guidance
Qualification
Required
PhD level students majoring in Biomedical Engineering, Pharmacometrics, Chemical Engineering, Statistics or a related discipline. Candidates must have an expected graduation date after August 2026
Proficiency in R or Python for data manipulation and visualization is required
Familiarity with ggplot2, tidyverse, or matplotlib/seaborn is required
Foundational understanding of PK/PD concepts (compartmental models, exposure–response) and statistical inference is required
Ability to report onsite to Boston, MA 3-5 days per week. This role will not provide relocation assistance
US Work Authorization is required at time of application
This role will not be providing OPT support
Preferred
Exposure to NONMEM, Monolix, or similar tools is a plus
Experience with MATLAB/Julia/Mathematica or QSP platforms is a plus
Company
AstraZeneca
AstraZeneca is a pharmaceutical company that discovers, develops, manufactures, and markets prescription medicines. It is a sub-organization of Investor.
Funding
Current Stage
Public CompanyTotal Funding
$5.26B2024-07-30Post Ipo Debt· $1.51B
2023-02-28Post Ipo Debt· $2.25B
2023-02-24Post Ipo Debt· $1.5B
Recent News
2026-01-12
Business Standard India
2026-01-11
2026-01-11
Company data provided by crunchbase